tm logo
Irpaliv
FORMALIZED

on 28 Feb 2024

Last Applicant/ Owned by

Abbisko Therapeutics Co., Ltd.

No. 3, Lane 898, HaLei Road,China (Shanghai) Pilot Free Trade Zone201203 Shanghai

CN

Serial Number

2312898 filed on 26th Dec 2023

Irpaliv

Trademark usage description

medicines for human purposes namely, medicinal preparations for the treatment of cancer; capsules for medicines, namely, coated capsule medicines for Read More

Classification Information


Class [005]
Medicines for human purposes namely, medicinal preparations for the treatment of cancer; capsules for medicines, namely, coated capsule medicines for prevention and treatment of human diseases, namely, anti-tumor purposes; pharmaceutical preparations and substances for the treatment of cancer; chemico-pharmaceutical preparations namely, chemical preparations for pharmaceutical or medical purposes, namely for use in the treatment of cancer; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; chemical preparations for medical and pharmaceutical use for treating oncological diseases, namely, liver cancer; pharmaceutical preparations in the form of injections for tumor suppression; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; pharmaceutical preparations for human biomedicine, namely, cancer therapy.


Classification kind code

12

Mark Details


Serial Number

2312898

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 29th Feb 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 28th Feb 2024
Created
Submitted for opposition 31
on 28th Feb 2024
Formalized
Submitted for opposition 228
on 26th Dec 2023
International Registration
Submitted for opposition 30
on 26th Dec 2023
Filed